# FDA Inspection 716363 - Azur Pharma, Inc. - April 01, 2011

Source: https://www.keypedia.com/records/fda_inspections/azur-pharma-inc/80c90f1d-1755-42c2-b032-1345eb4a97e6
Source feed: FDA_Inspections

> FDA Inspection 716363 for Azur Pharma, Inc. on April 01, 2011. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 716363
- Company Name: Azur Pharma, Inc.
- Inspection Date: 2011-04-01
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 748494 - 2011-09-27](https://www.keypedia.com/records/fda_inspections/azur-pharma-inc/75884608-234e-4c25-a2ba-dd3cb8c8d79c)
- [FDA Inspection 610650 - 2009-09-10](https://www.keypedia.com/records/fda_inspections/azur-pharma-inc/ac8be6b5-402a-4aa8-ac89-e5272d064e6c)

Company: https://www.keypedia.com/companies/azur-pharma-inc/a0062e24-5101-4d39-8ae4-24c693dff2c8

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c